{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:30:09Z","timestamp":1761129009513},"reference-count":0,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[1992,1,1]],"date-time":"1992-01-01T00:00:00Z","timestamp":694224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1992,1]]},"abstract":"<jats:p>Sparfloxacin was more potent than other quinolones (tosufloxacin, lomefloxacin, ciprofloxacin, ofloxacin, fleroxacin, enoxacin, and norfloxacin) and as potent as minocycline and doxycycline in activity against Chlamydia trachomatis in vitro and in vivo. Sparfloxacin was more bactericidal than minocycline against C. trachomatis D\/UW-3\/Cx.<\/jats:p>","DOI":"10.1128\/aac.36.1.188","type":"journal-article","created":{"date-parts":[[2012,6,28]],"date-time":"2012-06-28T00:05:50Z","timestamp":1340841950000},"page":"188-190","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["In vitro and in vivo activities of sparfloxacin, other quinolones, and tetracyclines against Chlamydia trachomatis"],"prefix":"10.1128","volume":"36","author":[{"given":"K","family":"Nakata","sequence":"first","affiliation":[{"name":"Department of Urology, School of Medicine, Kobe University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Maeda","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Kobe University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Kobe University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Kobe University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Umezu","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Kobe University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Kamidono","sequence":"additional","affiliation":[{"name":"Department of Urology, School of Medicine, Kobe University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.36.1.188","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.36.1.188","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T15:26:42Z","timestamp":1645457202000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.36.1.188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1992,1]]}},"alternative-id":["10.1128\/AAC.36.1.188"],"URL":"https:\/\/doi.org\/10.1128\/aac.36.1.188","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,1]]},"assertion":[{"value":"1992-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}